Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance
Clinical trial NCT02606266 · TERMINATED
Trial details
- NCT number
- NCT02606266
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2018-07-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.